[HTML][HTML] Ischemia and reperfusion injury in kidney transplantation: relevant mechanisms in injury and repair

GJ Nieuwenhuijs-Moeke, SE Pischke… - Journal of clinical …, 2020 - mdpi.com
Ischemia and reperfusion injury (IRI) is a complex pathophysiological phenomenon,
inevitable in kidney transplantation and one of the most important mechanisms for non-or …

[HTML][HTML] Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment

M Salvadori, G Rosso, E Bertoni - World journal of transplantation, 2015 - ncbi.nlm.nih.gov
Ischemia/reperfusion injury is an unavoidable relevant consequence after kidney
transplantation and influences short term as well as long-term graft outcome. Clinically …

Stem cell therapy for ischemic heart diseases

H Yu, K Lu, J Zhu, J Wang - British medical bulletin, 2017 - academic.oup.com
Introduction Ischemic heart diseases, especially the myocardial infarction, is a major hazard
problem to human health. Despite substantial advances in control of risk factors and …

Extracellular vesicles in renal diseases: more than novel biomarkers?

U Erdbrügger, TH Le - Journal of the American Society of …, 2016 - journals.lww.com
Extracellular vesicles from the urine and circulation have gained significant interest as
potential diagnostic biomarkers in renal diseases. Urinary extracellular vesicles contain …

[HTML][HTML] Incidence and outcomes of acute kidney injury after cardiac surgery using either criteria of the RIFLE classification

MG Lagny, F Jouret, JN Koch, F Blaffart, AF Donneau… - BMC nephrology, 2015 - Springer
Background Adult cardiac surgery is significantly associated with the development of acute
kidney injury (AKI). Still, the incidence and outcomes of AKI vary according to its definition …

[HTML][HTML] Infusion of mesenchymal stromal cells after deceased liver transplantation: a phase I–II, open-label, clinical study

O Detry, M Vandermeulen, MH Delbouille, J Somja… - Journal of …, 2017 - Elsevier
Background & Aims Mesenchymal stromal cell (MSC) infusion could be a means to establish
tolerance in solid organ recipients. The aim of this prospective, controlled, phase I study was …

[HTML][HTML] IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway

M Bai, L Zhang, B Fu, J Bai, Y Zhang, G Cai, X Bai… - Kidney international, 2018 - Elsevier
Mesenchymal stem cells (MSCs) are effective for the management of experimental ischemia-
reperfusion acute kidney injury (IRI-AKI). Immune modulation is one of the important …

[HTML][HTML] Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study

P Erpicum, L Weekers, O Detry, C Bonvoisin… - Kidney international, 2019 - Elsevier
Mesenchymal stromal cells (MSCs) exhibit anti-inflammatory and immune-regulatory
properties, and preclinical studies suggest a potential benefit in solid organ transplantation …

Insight into SUCNR1 (GPR91) structure and function

J Gilissen, F Jouret, B Pirotte, J Hanson - Pharmacology & therapeutics, 2016 - Elsevier
Abstract SUCNR1 (or GPR91) belongs to the family of G protein-coupled receptors (GPCR),
which represents the largest group of membrane proteins in human genome. The majority of …

[HTML][HTML] The macrophage response is driven by mesenchymal stem cell-mediated metabolic reprogramming

N Luque-Campos, FA Bustamante-Barrientos… - Frontiers in …, 2021 - frontiersin.org
Mesenchymal stem cells (MSCs) are multipotent adult stromal cells widely studied for their
regenerative and immunomodulatory properties. They are capable of modulating …